OBJECTIVE
To research the plasmic metabolites and metabolic pathway of Xin-blood stasis syndrome (XBSS).
METHODS
Plasma metabolic products in patients of coronary heart disease (CHD) with XBSS or non-XBSS and subjects in the control group were identified by gas chromatographic mass spectrometry